The market for Radiofrequency Ablation Devices was estimated to be worth $ 3.2 billion in 2021, and it is anticipated to increase to $ 11.3 billion by 2027, with a CAGR of 11.9% during forecast period 2022 and 2027.
Radio Frequency Ablation (RFA) or fulguration is a minimally invasive (MI) procedure that involves the ablation of defective tissues using heat generated by alternating current with a frequency range of (350 to 500 kHz). RFA helps the needle electrode into a cancerous tumor using CT (Computerized Tomography), MRI (Magnetic resonance Imaging), and ultrasound technologies. The management of pain and the therapy of cardiovascular problems both make extensive use of this procedure. The trend for less invasive operations and the rising prevalence of chronic and cardiovascular diseases are the main market drivers. By 2060, 17.9 million people in Europe and 12 million Americans are expected to have atrial fibrillation (AF), according to the Centers for Disease Control and Prevention (CDC).
The rise in the number of incidences of cardiovascular disease and cancer (Lung Cancer, liver cancer, kidney cancer, bone cancer, hepatocellular carcinoma, pancreatic cancer, bile duct cancer, and so on) around the world is one of the key factors driving the market's overall expansion. With a CAGR of 12.78% and total revenue of USD 996.173 Mn, the cardiac ablation industry is expanding gradually, considerably fueling the expansion of the global radio frequency ablation devices market. A significant portion of the market expansion is being driven by factors other than the increase in cancer and CVD cases, such as the increased demand for pain management (such as medication-assisted treatment of arthritis and other chronic pain conditions).
February 27, 2019: Medtronic Announces FDA Clearance and U.S. Launch of the Accurian Radio Frequency System for Nerve Tissue Ablation --
Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Accurian(TM) RF ablation platform, which conducts radio frequency (RF) ablation of nerve tissues. RF ablation is a minimally invasive procedure in which current produced by radio waves heats up a small area of nerve tissue to stop it from sending pain signals, thereby reducing pain. The Accurian system combines proprietary hardware and quad core processing with advanced software for power and temperature control resulting in consistent and predictable lesion formation. It also offers independent channel management and advanced smart features that may support procedural efficiency.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
North America accounted for the greatest share of the global market, with an overall CAGR of 11.973% and total revenue of 1.513 billion in 2020. This market's overall expansion is primarily being fueled by important aspects like the quick development of technological innovations in RFA and other medical equipment, the persistent rise in cancer incidence, and governmental spending on healthcare facilities.
However, throughout the predicted period of 2020-2030, the Asia-Pacific region had the greatest CAGR of the market. The primary reasons for this include the rapid advancements in China and India's healthcare infrastructures and the advent of new technology like multi-needle electrodes, which are all widely used.
The Radiofrequency Ablation Devices Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Radiofrequency Ablation Devices Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 11.9% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Medtronic, AngioDynamics, Ethicon, ZenoMed, AtriCure, Inc, Baren-Boym, Huaian Aofu Surgical Instruments Co., Ltd, MedSphere, Boston Scientific Corporation, Stryker, Cosman Medical, Inc, Jude medical, Smith & Nephew, Johnson & Johnson (J&J) Services, LLC, RF Medical Co Ltd, AtriCure, Inc., Inomed Medizintechnik GmbH, Bramsys Indústria e ComércioLtda, ENDO-FLEX GmbH, Sutter Medizintechnik Gmbh, Epimed International, Sfm Medical Devices Gmbh |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 135 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Radiofrequency Ablation Devices Market?
The Radiofrequency Ablation Devices Market is growing at a CAGR of 11.9% over the next 5 years.
Who are the key players in Radiofrequency Ablation Devices Market?
Medtronic, AngioDynamics, Ethicon, ZenoMed, AtriCure, Inc, Baren-Boym, Huaian Aofu Surgical Instruments Co., Ltd, MedSphere, Boston Scientific Corporation, Stryker, Cosman Medical, Inc, Jude medical, Smith & Nephew, Johnson & Johnson (J&J) Services, LLC, RF Medical Co Ltd, AtriCure, Inc., Inomed Medizintechnik GmbH, Bramsys Indústria e ComércioLtda, ENDO-FLEX GmbH, Sutter Medizintechnik Gmbh, Epimed International, Sfm Medical Devices Gmbh
What are the significant types of Radiofrequency Ablation Devices Market?
RF Generators, Reusable Products, Disposable Products
What are the major end-use applications of Radiofrequency Ablation Devices Market?
Prostate, Cardiac, Tumor, Other Pain
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.